Industry Sponsored Symposia
DAY 1 │ Thursday, 18 October 2018
| 17:00- 18:30 | INDUSTRY SPONSORED SYMPOSIUM 1: News in molecular allergology – Applying precision medicine in clinical practice Chairs: Philippe Eigenmann, Switzerland - Magnus Borres, Sweden Tree nut allergen component sensitization across Europe – lessons learnt from the Pronut study Philippe Eigenmann, Switzerland Meta analyses of the clinical utility of peanut and hazelnut components in allergy diagnosis Caroline Nilsson, Sweden LTP allergies - prevalence, diagnosis and clinical implications Olga Luengo, Spain IgE and IgG4 to allergen components for inclusion and monitoring of peanut OIT Brian Vickery, United States |
Room: |
DAY 2 │ Friday, 19 October 2018
| 12:00- 13:00 | INDUSTRY LUNCH SYMPOSIUM: Peanut Allergy in a Changing World Chair: Gideon Lack, United Kingdom Chair’s welcome and introduction peanut allergy landscape before and after LEAP Gideon Lack, United Kingdom Recent research advances in the management of peanut allergy Kirsten Beyer, Germany Understanding clinical trial design and terminology in food allergy Montserrat Fernández -Rivas, Spain Q&A |
Room:
Tivoli Congress Hall Supported by  |
| 13:00- 14:15 |
INDUSTRY SPONSORED SYMPOSIUM 2: Nutritional strategies targeting the gut microbiota & its role in early life allergy development Food allergy, where are we now? Ulrich Wahn, Germany The role of nutrition in gut microbiota development and early life immunity Glenn Gibson, United Kingdom Translating the latest scientific insights for the dietary management of allergy into clinical practice Carina Venter, United States |
Room: Carstensen Supported by |
| 16:30- 18:00 | INDUSTRY SPONSORED SYMPOSIUM 3: Peanut allergy in children: managing patients’ and caregivers’ expectations Chairs: Antonella Muraro, Italy - David Fleisher, United States Welcome and Introductions Antonella Muraro, Italy Burden of Peanut Allergy Disease in Europe – can we identify patients at risk of severe reactions? Paul Turner, United Kingdom How the standard of care in peanut allergy may evolve? Katharina Blümchen, Germany Overview of investigational epicutaneous immunotherapy for peanut allergy David Fleischer, United States Summary David Fleisher, United States Faculty Panel Q&A All faculty |
Room: Vandsalen Supported by  |
DAY 3 │ Saturday, 20 October 2018
| 11:30- 12:45 |
INDUSTRY SPONSORED SYMPOSIUM 4: |
Room: Carstensen Supported by  |